Condition
Cardiorenal Syndrome Type 1
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT06786728Not ApplicableEnrolling By InvitationPrimary
Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1
NCT06065163Not ApplicableUnknownPrimary
Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome
Showing all 2 trials